NDC 73377-036 - Telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-036
- Package NDCs from labels
- 73377-036-01, 73377-036-02, 73377-036-03, 73377-036-04, 73377-036-05, 73377-036-06, 73377-036-07, 73377-036-08, 73377-036-09
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Telmisartan - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-03-24 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-036-01 | Telmisartan | 250 g in 1 JAR | POWDER | 250 | 11 | |
| 73377-036-02 | Telmisartan | 50 g in 1 JAR | POWDER | 50 | 11 | |
| 73377-036-03 | Telmisartan | 42 g in 1 JAR | POWDER | 42 | 11 | |
| 73377-036-04 | Telmisartan | 1000 g in 1 JAR | POWDER | 1000 | 11 | |
| 73377-036-05 | Telmisartan | 100 g in 1 JAR | POWDER | 100 | 11 | |
| 73377-036-06 | Telmisartan | 950 g in 1 JAR | POWDER | 950 | 11 | |
| 73377-036-07 | Telmisartan | 5000 g in 1 JAR | POWDER | 5000 | 11 | |
| 73377-036-08 | Telmisartan | 46 g in 1 JAR | POWDER | 46 | 11 | |
| 73377-036-09 | Telmisartan | 85 g in 1 JAR | POWDER | 85 | 11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | bf8e95fa-d181-4b46-8609-497e14a73dc1 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | NuCare Pharmaceuticals, Inc. | 3f021f06-99df-48d1-e063-6394a90a8d0f | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan and hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 0c1bd0f4-034e-486c-ae46-2855c8c9ebda | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare LLC | 47c8eee0-f0b7-4bd8-97e9-0029aa1b37db | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | PD-Rx Pharmaceuticals, Inc. | 56a72ddf-c2a2-45ce-91b1-1fcfbff52c10 | 2025-05-01 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Bryant Ranch Prepack | 32489e86-0432-4d74-92f6-15e7450f52fa | 2025-04-29 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Bryant Ranch Prepack | 44e810d4-cf04-41d3-bdf8-0681210a669f | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Ascend Laboratories, LLC | 29bddc43-2809-4e1f-ae35-2865e15e9bb6 | 2025-03-29 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Jubilant Cadista Pharmacuticals Inc. | e1a907a7-fad9-a860-8639-4c6136c85734 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Micardis HCT | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | b078dae2-664d-4144-847a-3b9d9b557402 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | e2deff49-b75e-4aaa-8114-d5ea1e3a94a5 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | b4ae8694-2af4-4acb-8634-b40c1cb6fb41 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | f13e0919-5ee2-4855-b7c8-c8ab423769dd | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Lifestar Pharma LLC | 3ff464e6-7a36-4544-a06f-7848414f77fc | 2024-10-18 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Zydus Lifesciences Limited | 2e3cc412-fa44-4304-aabc-d6e412f81fbf | 2024-08-12 | U5SYW473RQ | |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | NuCare Pharmaceuticals,Inc. | a020e2a7-d1e7-8ae0-e053-2995a90abad3 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Aurobindo Pharma Limited | fef6532d-438a-435e-a61f-216dd8551339 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Lupin Pharmaceuticals, Inc. | a97fefa6-99e6-4eb7-9393-ab2252a2c7d8 | 2023-12-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Zydus Pharmaceuticals USA Inc. | e61c209a-4fc3-4f5c-b526-6412f0b8897c | 2023-11-08 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.